Research Article: Screening practices, efficacy, safety and adherence to biologic therapies in a South African tertiary hospital
Abstract:
Introduction: The high cost and concern of adverse events, particularly infections, limit the use of biologic therapies. We undertook this retrospective study to document their use for immune-mediated diseases, and explore the screening practices, efficacy, safety, and adherence to bDMARDs in a tertiary hospital.
No summary available.